Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

CRM1 and BRAF inhibition synergize and induce tumor regression in BRAF-mutant melanoma.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.